nCino to Participate in Upcoming Investor Events — Neutral

NCNO   GlobeNewsWire — August 27, 2025

WILMINGTON, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced its participation in the following investor conferences:

image for news nCino to Participate in Upcoming Investor Events

Donald Tremblay Joins Telesat as Chief Financial Officer — Neutral

TSAT   GlobeNewsWire — August 27, 2025

OTTAWA, Ontario, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Telesat (NASDAQ and TSX: TSAT), one of the world's largest and most innovative satellite operators, today announced the appointment of Donald Tremblay as its new Chief Financial Officer (CFO), effective October 20, 2025. A highly experienced CFO, Mr. Tremblay brings over 35 years of financial expertise and leadership, including at publicly listed companies in high-growth, capital intensive industries. He has deep experience in equity and debt capital market transactions, mergers and acquisitions, compliance, and risk management. Mr. Tremblay will be succeeding Andrew Browne, who announced in March of this year that he …

image for news Donald Tremblay Joins Telesat as Chief Financial Officer

Bread Financial Announces Approval of $200 Million Share Repurchase Program — Neutral

BFH   GlobeNewsWire — August 27, 2025

COLUMBUS, Ohio, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bread Financial® Holdings, Inc. (NYSE: BFH) (“Bread Financial” or the “Company”) today announced that its Board of Directors (the “Board”) has authorized a new plan to repurchase up to $200 million of shares of its common stock. There is no expiration date for the repurchase plan.

image for news Bread Financial Announces Approval of $200 Million Share Repurchase Program

Dyne Therapeutics to Present at Upcoming Investor Conferences — Neutral

DYN   GlobeNewsWire — August 27, 2025

WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that management is scheduled to present at the following upcoming investor conferences:

image for news Dyne Therapeutics to Present at Upcoming Investor Conferences

BridgeBio to Participate in September Investor Conferences — Neutral

BBIO   GlobeNewsWire — August 27, 2025

PALO ALTO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will host fireside chats at the following healthcare investor conferences:

image for news BridgeBio to Participate in September Investor Conferences

DALLAS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- DallasNews Corporation (Nasdaq: DALN) (the “Company” or “DallasNews”), the holding company of The Dallas Morning News and Medium Giant, announced today that its Board of Directors (the “Board”), following consultation with the Company's legal and financial advisors, reviewed and rejected the revised, non-binding proposal (the “Revised Alden Proposal”) received on August 19, 2025, from MNG Enterprises, Inc., an affiliate of Alden Global Capital (“Alden”), to acquire all of the issued and outstanding shares of the Company's common stock at $18.50 per share in cash. As previously announced, on July 9, 2025, DallasNews entered …

image for news DallasNews Rejects Revised Non-Binding Proposal from Affiliate of Alden Global Capital

MasterCraft Boat Holdings, Inc. Reports Fiscal 2025 Results — Neutral

MCFT   GlobeNewsWire — August 27, 2025

VONORE, Tenn., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2025 fourth quarter and year ended June 30, 2025.

image for news MasterCraft Boat Holdings, Inc. Reports Fiscal 2025 Results

Rezolute to Participate in Upcoming Investor Conferences — Neutral

RZLT   GlobeNewsWire — August 27, 2025

REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that management will participate in the following investor conferences:

image for news Rezolute to Participate in Upcoming Investor Conferences

Battle Born Batteries® to serve as the standard lithium power solution in Awaken RV's debut lineup Battle Born Batteries® to serve as the standard lithium power solution in Awaken RV's debut lineup

image for news Dragonfly Energy Partners with Awaken RV to Power Next-Generation Fiberglass Travel Trailers

WINSTON-SALEM, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that senior members of the management team will be participating in the following two upcoming healthcare conferences in September:

image for news ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference

Unmatched efficiency and versatility for defense, AI, and energy markets through co-located and process-optimized rare earth separation, fluoride, and metallization FISHERS, IN / ACCESS Newswire / August 27, 2025 / In a major step toward ending America's reliance on foreign rare earth supply chains, American Resources Corporation's (NASDAQ:AREC) ReElement Technologies ("ReElement") has signed an MOU with Principal Mineral Co. Inc. ("Principal Mineral") to co-develop the most advanced U.S. rare earth production capability, integrating separation, fluoride production, and metallization as a singular process under one roof. This strategic alliance will create the world's most flexible and efficient rare earth midstream capability, …

image for news ReElement and Principal Mineral Partner to Provide Integrated Rare Earth Separation and Metal Production Capability in the United States

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: European Society of Cardiology (ESC) Congress 2025 – August 29 - September 1, 2025 Title: A Randomized, Placebo-controlled Phase 3 Study of Plozasiran in Patients With FCS: Interim Analysis of Open Label Extension of PALISADE at 1 Year Date/Time: August 30, 2025, 5:15 pm CET Type: Moderated Poster Presentation Title: Safety and E.

image for news Arrowhead Pharmaceuticals to Participate in Upcoming September 2025 Conferences

PVH: Better Q2 Results May Be A Pull-Forward Ahead Of Tariffs — Neutral

PVH   Seeking Alpha — August 27, 2025

PVH's Q2 results beat expectations, but margin pressure and tariff impacts remain significant headwinds, limiting upside. Much of the Q2 strength was driven by retailers and consumers pulling forward purchases ahead of tariff increases, making future growth less certain. Guidance for the second half is weaker, with management not raising full-year EPS, despite FX tailwinds, signaling caution for upcoming quarters.

image for news PVH: Better Q2 Results May Be A Pull-Forward Ahead Of Tariffs

Comprehensive Data-Driven Report Identifies Top Five Trends Shaping the Nearly $150 Billion U.S. Snacking Market CHICAGO , Aug. 27, 2025 /PRNewswire/ -- Conagra Brands, Inc. (NYSE: CAG), a leading maker of iconic snacks including Slim Jim® meat snacks, Orville Redenbacher's® popcorn, DAVID® Seeds, Angie's BOOMCHICKAPOP® popcorn, and Snack Pack® desserts, released today its inaugural Future of Snacking 2025 report. Leveraging Conagra's cutting edge demand science and insights expertise, in partnership with Circana LLC, the report provides a data-driven look at the $148.6 billion U.S. snacking market and the evolving trends shaping consumer behavior.1 The report identifies five key trends that …

image for news Conagra Brands Unveils Future of Snacking 2025 Report, Spotlighting Bold Flavors, Better-For-You Choices, and On-the-Go Innovation

Context Therapeutics to Participate in Upcoming Investor Conferences — Neutral

CNTX   GlobeNewsWire — August 27, 2025

PHILADELPHIA, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced that the Company will participate in the following investor conferences:

image for news Context Therapeutics to Participate in Upcoming Investor Conferences

MERRILLVILLE, Ind.--(BUSINESS WIRE)--NiSource (NYSE: NI), one of the largest fully regulated utility companies in the United States, has published its 2024 sustainability report, emphasizing the company's dedication to operational excellence, safety, customer satisfaction and environmental stewardship. Titled Powering Vibrant and Viable Communities, the report details NiSource's advancements in sustainability, showcasing how the company has enhanced existing standards while leveraging technolog.

image for news NiSource Unveils Its Annual Sustainability Report, Showcasing Progress Towards Goals

DAYTON, Ohio--(BUSINESS WIRE)--REX American Resources Corporation (“REX” or the “Company”) (NYSE: REX), a leading ethanol production company, today announced financial and operational results for the Company's fiscal second quarter 2025. The Company also announced a 2-for-1 stock split for shareholders of record as of September 8, 2025. REX American Resources' fiscal second quarter 2025 results principally reflect its interests in six ethanol production facilities. The One Earth Energy, LLC (“O.

image for news REX American Resources Reports Fiscal Second Quarter 2025 Net Income Per Share Attributable to REX Common Shareholders of $0.43

22V Research's head of technical strategy John Roque likes the way Tesla's stock chart is looking.

image for news Tesla Stock Is Up as It Builds a 'Big Base.' What Is Pointing to Big Gains.

Up 122%, Why NIO Stock Can't Stop Surging — Positive

NIO   24/7 Wall Street — August 27, 2025

Key Points in This Article: NIO (NIO) lagged in China's EV market but has surged 122% since its April lows.

image for news Up 122%, Why NIO Stock Can't Stop Surging

The bear case for Eli Lilly has now played out following the reaction to the drugmaker's oral obesity drug trial, an analyst said Wednesday in upgrading the stock.

image for news The bear case on Eli Lilly has played out, says only firm to have called it a sell